Health & Wellness
Wednesday, August 19, 2026 · Berkeley County
Deworming and Scabies Medications Marketed as Cancer Treatments
An investigation found deworming and scabies medications are being sold as cancer treatments. One terminally ill man reported a stair lift salesman offered him these drugs, claiming they could shrink tumors.
New Mexico Judge Imposes Child Safety Measures on Meta Platforms
A New Mexico judge has ordered Meta to implement new safeguards for child users on its platforms. The ruling follows a lawsuit alleging the company's products contribute to mental health issues in young people. This decision could influence similar legal challenges nationwide.
Wednesday, August 19, 2026
Student Loan Defaults Rise After Pandemic Protections End
Approximately 9.5 million federal student loan borrowers, representing one in five, have entered default status. This occurs after they miss payments for nine months or more. The increase follows the expiration of pandemic-era payment pauses.
Wednesday, August 19, 2026
Cyclosporiasis Cases Reported Across Over Half of US States
Cyclosporiasis, a parasitic stomach illness, has affected individuals across more than half of U.S. states. The illness has resulted in thousands of reported cases, with some requiring hospitalization. Medical experts highlight symptoms and prevention methods.
Wednesday, August 19, 2026
FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment
The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.
Wednesday, August 19, 2026
Report Details Closure of HIV/AIDS Treatment Sites Following Funding Reductions
A recent report highlights the closure of over 1,700 HIV/AIDS treatment sites. This development follows funding adjustments to USAID and the PEPFAR program, which has supported over 26 million lives since 2003.
Wednesday, August 19, 2026
FDA Considers Approval for Moderna's mRNA Flu Vaccine
The FDA is evaluating Moderna's mRNA-based flu vaccine. This decision has the potential to introduce a new type of influenza shot and influence the biotech industry.
Wednesday, August 19, 2026